Trial NCT03701308

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2018-02130
Secondary IDs: A041701 NCI-2018-02130 U10CA180821

Last trial update was posted on 2024-03-25

MeSH Interventions

Cytarabine Daunorubicin

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute

Other Conditions

Acute Myeloid Leukemia

Stopping Reasons

End of Initial Phase of Multi-phase protocol

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID